Published in BMJ on July 15, 2000
Toxoplasma gondii: from animals to humans. Int J Parasitol (2000) 10.45
Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev (2012) 4.07
Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg Infect Dis (2003) 2.73
Recently acquired Toxoplasma gondii infection, Brazil. Emerg Infect Dis (2006) 1.79
Seroprevalence of Toxoplasma gondii infection in pet dogs in Lanzhou, Northwest China. Parasit Vectors (2011) 1.71
Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health (2005) 1.57
Antenatal screening for Toxoplasma gondii infection at a tertiary care hospital in Riyadh, Saudi Arabia. Ann Saudi Med (2011) 1.56
The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002. Arch Dis Child (2006) 1.49
Toxoplasma gondii Infection in Alpine Red Deer (Cervuselaphus): Its Spread and Effects on Fertility. PLoS One (2015) 1.45
Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect Dis (2006) 1.35
Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico. BMC Infect Dis (2006) 1.35
Identification of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol (2011) 1.28
Seroprevalence of Toxoplasma gondii infection in household and stray cats in Lanzhou, northwest China. Parasit Vectors (2011) 1.24
Drug repurposing and human parasitic protozoan diseases. Int J Parasitol Drugs Drug Resist (2014) 1.23
Toxoplasma gondii infection in the United States, 1999-2000. Emerg Infect Dis (2003) 1.22
Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infect Dis (2007) 1.18
Toxoplasma seroprevalence in a rural population in France: detection of a household effect. BMC Infect Dis (2009) 1.11
Seroprevalence and sources of Toxoplasma infection among indigenous and immigrant pregnant women in Taiwan. Parasitol Res (2008) 1.10
Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vaccine Immunol (2011) 1.08
Changing climate-changing pathogens: Toxoplasma gondii in North-Western Europe. Parasitol Res (2009) 1.07
Quantitative estimation of the viability of Toxoplasma gondii oocysts in soil. Appl Environ Microbiol (2012) 1.04
Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother (2004) 1.01
Symptomatic toxoplasma infection due to congenital and postnatally acquired infection. Arch Dis Child (2006) 1.01
Direct genotypic characterization of Toxoplasma gondii strains associated with congenital toxoplasmosis in Tunisia (North Africa). Am J Trop Med Hyg (2010) 0.98
Toxoplasma gondii oocyst-specific antibodies and source of infection. Emerg Infect Dis (2010) 0.98
Toxoplasma gondii seropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar. Am J Trop Med Hyg (2010) 0.97
Seroprevalence of human toxocariasis in Denmark. Clin Vaccine Immunol (2009) 0.97
Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis. PLoS Negl Trop Dis (2013) 0.96
Evaluation of a commercial ELISA kit for detection of antibodies against Toxoplasma gondii in serum, plasma and meat juice from experimentally and naturally infected sheep. Parasit Vectors (2013) 0.94
Seroepidemiology of Toxoplasma gondii Infection among healthy blood donors in Taiwan. PLoS One (2012) 0.93
Prospective study of congenital toxoplasmosis screening with use of IgG avidity and multiplex nested PCR methods. J Clin Microbiol (2011) 0.93
Congenital toxoplasmosis--a report on the Danish neonatal screening programme 1999-2007. J Inherit Metab Dis (2010) 0.92
Toxoplasma infection in pregnant women: a current status in Songklanagarind hospital, southern Thailand. Parasit Vectors (2014) 0.90
Incidence of maternal Toxoplasma infections in pregnancy in Upper Austria, 2000-2007. BMC Infect Dis (2011) 0.90
Increased Toxoplasma gondii positivity relative to age in 125 Scottish sheep flocks; evidence of frequent acquired infection. Vet Res (2011) 0.90
Prevalence of Toxoplasma gondii antibodies, circulating antigens and DNA in stray cats in Shanghai, China. Parasit Vectors (2012) 0.90
Toxoplasma gondii in Capybara (Hydrochaeris hydrochaeris) antibodies and DNA detected by IFAT and PCR. Parasitol Res (2010) 0.90
A comparative analysis of coprologic diagnostic methods for detection of Toxoplama gondii in cats. Am J Trop Med Hyg (2010) 0.90
In Romania, exposure to Toxoplasma gondii occurs twice as often in swine raised for familial consumption as in hunted wild boar, but occurs rarely, if ever, among fattening pigs raised in confinement. Parasitol Res (2013) 0.89
Seroprevalence and risk factors for toxoplasmosis among antenatal women in London: a re-examination of risk in an ethnically diverse population. Eur J Public Health (2012) 0.89
Latent toxoplasmosis in patients with different malignancy: a hospital based study. J Clin Med Res (2010) 0.89
First report of Toxoplasma gondii prevalence in Tibetan pigs in Tibet, China. Vector Borne Zoonotic Dis (2012) 0.89
Seroprevalence of Toxoplasma gondii in Sheep, Cattle and Horses in Urmia North-West of Iran. Iran J Parasitol (2011) 0.89
Seroprevalence of Toxoplasma gondii infection among veterinary staff in Ontario, Canada (2002): implications for teratogenic risk. BMC Infect Dis (2003) 0.89
Detection of Toxoplasma gondii oocysts in environmental soil samples using molecular methods. Eur J Clin Microbiol Infect Dis (2008) 0.88
Risk factors for ocular toxoplasmosis in Brazil. Epidemiol Infect (2013) 0.88
Interferon-γ restricts Toxoplasma gondii development in murine skeletal muscle cells via nitric oxide production and immunity-related GTPases. PLoS One (2012) 0.87
Observational study to assess pregnant women's knowledge and behaviour to prevent toxoplasmosis, listeriosis and cytomegalovirus. BMC Pregnancy Childbirth (2013) 0.87
Detection and Identification of Toxoplasma gondii Type One Infection in Sheep Aborted Fetuses in Qazvin Province of Iran. Iran J Parasitol (2012) 0.87
Investigating the Determinants of Toxoplasma gondii Prevalence in Meat: A Systematic Review and Meta-Regression. PLoS One (2016) 0.86
Sources of Toxoplasma gondii infection in pregnancy. Until rates of congenital toxoplasmosis fall, control measures are essential. BMJ (2000) 0.85
Mic1-3 Knockout Toxoplasma gondii is a good candidate for a vaccine against T. gondii-induced abortion in sheep. Vet Res (2010) 0.85
Vaccination of pigs with the S48 strain of Toxoplasma gondii--safer meat for human consumption. Vet Res (2015) 0.85
Toxoplasma gondii antibody profile in HIV-infected pregnant women and the risk of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis (2008) 0.84
Toxoplasmosis and pregnancy. Can Fam Physician (2014) 0.84
Drinking water source and human Toxoplasma gondii infection in the United States: a cross-sectional analysis of NHANES data. BMC Public Health (2014) 0.83
Detection of Toxoplasma gondii DNA in horse meat from supermarkets in France and performance evaluation of two serological tests. Parasite (2015) 0.82
Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections. Microbiol Mol Biol Rev (2015) 0.82
Toxoplasmosis during pregnancy: a case report and review of the literature. Hippokratia (2008) 0.81
Seroprevalence of Toxoplasma gondii in wild boars (Sus scrofa) from Central Italy. Parasite (2013) 0.81
Seroprevalence of Toxoplasma gondii in free-ranging wild boars hunted for human consumption in Estonia. Acta Vet Scand (2015) 0.80
Toxoplasmosis in a patient who was immunocompetent: a case report. J Med Case Rep (2011) 0.80
Diagnosis of pulmonary infection with Toxoplasma gondii in immunocompromised HIV-positive patients by real-time PCR. Eur J Clin Microbiol Infect Dis (2006) 0.80
Prevalence and risk factors of Toxoplasma gondii in fattening pigs farm from Yucatan, Mexico. Biomed Res Int (2013) 0.80
Seroprevalence and incidence of Toxoplasma gondii among apparently healthy and visually or hearing disabled children in Taiz City, Yemen. Korean J Parasitol (2010) 0.80
Seroprevalence of Toxoplasma gondii infection and associated risk factors among pregnant women in Debre Tabor, Northwest Ethiopia. BMC Res Notes (2015) 0.80
Isolation and genotyping of viable Toxoplasma gondii from sheep and goats in Ethiopia destined for human consumption. Parasit Vectors (2014) 0.80
Adverse socioeconomic conditions and oocyst-related factors are associated with congenital toxoplasmosis in a population-based study in Minas Gerais, Brazil. PLoS One (2014) 0.79
Toxoplasmosis preventive behavior and related knowledge among Saudi pregnant women: an exploratory study. Glob J Health Sci (2013) 0.79
Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women following antenatal care at Mizan Aman General Hospital, Bench Maji Zone (BMZ), Ethiopia. BMC Infect Dis (2016) 0.78
Pathogenicity and phenotypic sulfadiazine resistance of Toxoplasma gondii isolates obtained from livestock in northeastern Brazil. Mem Inst Oswaldo Cruz (2016) 0.78
Risk factors for acute Toxoplasma gondii diseases in Taiwan: a population-based case-control study. PLoS One (2014) 0.78
Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries. J Parasit Dis (2014) 0.78
When should a trophically and vertically transmitted parasite manipulate its intermediate host? The case of Toxoplasma gondii. Proc Biol Sci (2013) 0.78
The prevalence and genotypic analysis of Toxoplasma gondii from individuals in Scotland, 2006-2012. Parasit Vectors (2016) 0.78
Seroprevalence of anti-Toxoplasma gondii antibodies in cattle and pigs in Ibadan, Nigeria. J Parasit Dis (2013) 0.78
Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon. BMC Res Notes (2016) 0.77
The relationship between owning a cat and the risk of developing a brain cancer in a prospective study of UK women: comment on Thomas et al. Biol Lett (2012) 0.77
Parasite distribution and associated immune response during the acute phase of Toxoplasma gondii infection in sheep. BMC Vet Res (2014) 0.77
Toxoplasma gondii infections among pregnant women, children and HIV-seropositive persons in Accra, Ghana. Trop Med Health (2016) 0.77
HUMAN TOXOPLASMOSIS OUTBREAKS AND THE AGENT INFECTING FORM. FINDINGS FROM A SYSTEMATIC REVIEW. Rev Inst Med Trop Sao Paulo (2015) 0.76
Towards Universal Screening for Toxoplasmosis: Rapid, Cost-Effective, and Simultaneous Detection of Anti-Toxoplasma IgG, IgM, and IgA Antibodies by Use of Very Small Serum Volumes. J Clin Microbiol (2016) 0.76
Caspase-11 Modulates Inflammation and Attenuates Toxoplasma gondii Pathogenesis. Mediators Inflamm (2016) 0.76
First report of Toxoplasma gondii seroprevalence in wild-caught Caribbean African green monkeys. Parasit Vectors (2014) 0.76
Comparison of methods for detection of Toxoplasma gondii in tissues of naturally exposed pigs. Parasitol Res (2011) 0.76
Prevalence and incidence of toxoplasmosis: a retrospective analysis of mother-child examinations, Styria, Austria, 1995 to 2012. Euro Surveill (2016) 0.75
Seroprevalence of Toxoplasma gondii Infection in Wild Boars, Wild Rabbits, and Wild Chickens in Hubei Province, China. Korean J Parasitol (2017) 0.75
Mechanisms and pathways of Toxoplasma gondii transepithelial migration. Tissue Barriers (2016) 0.75
Seroprevalence of Toxoplasma gondii infection among pregnant women in Cameroon. J Public Health Africa (2011) 0.75
Cytomegalovirus, Toxoplasma gondii and Rubella Vertical Transmission Rates According to Mid-trimester Amniocentesis: A Retrospective Study. Int J Prev Med (2015) 0.75
Toxoplasmosis seroprevalence in relation to knowledge and practice among pregnant women in Dhahran, Saudi Arabia. Pathog Glob Health (2015) 0.75
Toxoplasma gondii survey in cats from two environments of the city of Rio de Janeiro, Brazil by Modified Agglutination Test on sera and filter-paper. Parasit Vectors (2017) 0.75
Seroprevalence and determinants of toxoplasmosis in pregnant women attending antenatal clinic at the university teaching hospital, Lusaka, Zambia. BMC Infect Dis (2017) 0.75
Toxoplasmosis in HIV infection: An overview. Trop Parasitol (2016) 0.75
Factors associated with Toxoplasma gondii infection in confined farrow-to-finish pig herds in western France: an exploratory study in 60 herds. Parasit Vectors (2016) 0.75
Toxoplasma gondii seroprevalence in the Portuguese population: comparison of three cross-sectional studies spanning three decades. BMJ Open (2016) 0.75
Detection of Toxoplasma gondii oocysts in soils in northwestern China using a new semi-nested PCR assay. BMC Vet Res (2014) 0.75
Seroepidemiology of toxoplasmosis in rural and urban communities from Los Rios Region, Chile. Infect Ecol Epidemiol (2016) 0.75
Toxoplasmosis and Toxocariasis: An Assessment of Human Immunodeficiency Virus Comorbidity and Health-Care Costs in Canada. Am J Trop Med Hyg (2016) 0.75
DNA Amplification Techniques for the Detection of Toxoplasma gondii Tissue Cysts in Meat Producing Animals: A Narrative Review Article. Iran J Parasitol (2017) 0.75
Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med (1994) 4.32
Results of 20-year follow-up of congenital toxoplasmosis. Lancet (1986) 3.00
Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group . Lancet (1999) 2.54
[Epidemiological study on toxoplasmosis: the influence of cooking slaughter-animal meat on the incidence of human infection]. Rev Fr Etud Clin Biol (1965) 2.09
Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am J Epidemiol (1996) 2.04
Congenital toxoplasmosis. BMJ (1992) 1.71
Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM. J Clin Pathol (1989) 1.61
Modeling age- and time-specific incidence from seroprevalence:toxoplasmosis. Am J Epidemiol (1993) 1.50
Persistence of tissue cysts in edible tissues of cattle fed Toxoplasma gondii oocysts. Am J Vet Res (1993) 1.44
Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect (1999) 1.42
Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii. J Clin Pathol (1992) 1.27
Long-term persistence of Toxoplasma gondii in tissues of pigs inoculated with T gondii oocysts and effect of freezing on viability of tissue cysts in pork. Am J Vet Res (1988) 1.26
Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the U.K. J Infect (1998) 1.16
Infectivity of Toxoplasma gondii in mutton following curing, smoking, freezing or microwave cooking. Int J Food Microbiol (1992) 1.16
Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The Study Group. Pediatr Infect Dis J (1995) 1.15
Risk factors for recent toxoplasma infection in pregnant women in Naples. Epidemiol Infect (1996) 1.14
Prevalence of toxoplasma IgG among pregnant women in west London according to country of birth and ethnic group. BMJ (1993) 1.12
Strategies to reduce transmission of Toxoplasma gondii to animals and humans. Vet Parasitol (1996) 1.12
Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect (1998) 1.10
Congenital toxoplasmosis: prevention, screening and treatment. J Hosp Infect (1995) 1.08
[Toxoplasmosis among pregnant women in France : Seroprevalence, seroconversion and knowledge levels. Trends 1965-1995.]. Med Mal Infect (1996) 1.04
Prevalence of Toxoplasma gondii antibodies in gravidas and recently aborted women and study of risk factors. Eur J Epidemiol (1990) 1.03
Toxoplasmosis in a flock of sheep: some investigations into its source and control. Vet Rec (1986) 0.96
Modelling toxoplasma incidence from longitudinal seroprevalence in Stockholm, Sweden. Parasitology (1993) 0.95
Detection of Toxoplasma gondii in cured meats. Int J Food Microbiol (1998) 0.94
A survey of health education material for the primary prevention of congenital toxoplasmosis. Commun Dis Rep CDR Rev (1995) 0.93
Regression methods for estimating attributable risk in population-based case-control studies: a comparison of additive and multiplicative models. Am J Epidemiol (1991) 0.91
[20 years of screening for toxoplasmosis in pregnant women. The Liège experience in 20,000 pregnancies]. Rev Med Liege (1990) 0.87
[Congenital toxoplasmosis, evaluation of the prevention policy]. Presse Med (1994) 0.86
Toxoplasmosis: survey of policy and practice in UK antenatal clinics. Midwives Chron (1994) 0.85
Survey of local policies for prevention of congenital toxoplasmosis. Commun Dis Rep CDR Rev (1994) 0.85
Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet (2000) 3.94
Raised serum levels of tumour necrosis factor in parasitic infections. Lancet (1986) 3.23
Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet (1999) 2.97
Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group . Lancet (1999) 2.54
Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis (1996) 2.43
Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ (2003) 2.34
Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed (2010) 2.32
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes (1999) 2.16
Malaria chemoprophylaxis: why mefloquine? Lancet (1990) 2.13
The Thucydides syndrome. A new hypothesis for the cause of the plague of Athens. N Engl J Med (1985) 2.04
Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am J Epidemiol (1996) 2.04
Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol (1983) 2.02
Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol (1999) 1.92
Birmingham hip resurfacing: the prevalence of failure. J Bone Joint Surg Br (2010) 1.88
MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety. J Neurol Neurosurg Psychiatry (2010) 1.84
Paternal age effect in Down's syndrome. Ann Hum Genet (1977) 1.84
Changes in clinical indications for community antibiotic prescribing for children in the UK from 1996 to 2006: will the new NICE prescribing guidance on upper respiratory tract infections just be ignored? Arch Dis Child (2008) 1.80
Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol (2001) 1.78
Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.74
Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components. Immunol Rev (1989) 1.73
Incidence study of Down's syndrome in Copenhagen, 1960-1971; with chromosome investigation. Ann Hum Genet (1976) 1.72
Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol Biochem Parasitol (1991) 1.70
Acceptance, reliability and confidence of diagnosis of fetal and neonatal virtuopsy compared with conventional autopsy: a prospective study. Ultrasound Obstet Gynecol (2012) 1.68
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant (2001) 1.66
HIV and infertility: time to treat. There's no justification for denying treatment to parents who are HIV positive. BMJ (2001) 1.62
The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull World Health Organ (1999) 1.56
Blockade of the renin-angiotensin and endothelin systems on progressive renal injury. Hypertension (2000) 1.56
Serotypes of Ureaplasma urealyticum isolated from normal pregnant women and patients with pregnancy complications. J Clin Microbiol (1988) 1.54
The painful crisis of homozygous sickle cell disease. A study of the risk factors. Arch Intern Med (1987) 1.53
Inherited metabolic diseases in the sudden infant death syndrome. Arch Dis Child (1991) 1.50
The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002. Arch Dis Child (2006) 1.49
Dynamic sonography with provocation of pain for diagnosis of symptomatic mobile kidneys. Eur J Surg (2001) 1.46
HIV and reproductive care--a review of current practice. BJOG (2006) 1.45
Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol (2001) 1.44
Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology (2010) 1.44
Quantitative bacterial examination of domestic water supplies in the Lesotho Highlands: water quality, sanitation, and village health. Bull World Health Organ (1999) 1.43
Transforming growth factor-beta1 and tumor growth factor-beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy. Transplantation (2001) 1.43
Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect (1999) 1.42
Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies. Clin Diagn Lab Immunol (1996) 1.41
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia (2002) 1.40
Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes (1994) 1.40
The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tuber Lung Dis (1994) 1.39
Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes. Med J Aust (2001) 1.39
Bilateral papillitis in ocular toxoplasmosis. Eye (Lond) (2009) 1.39
View 1: Assisted conception in couples with HIV infection. Sex Transm Infect (2003) 1.38
Usefulness of Toxoplasma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis. J Clin Microbiol (2004) 1.37
Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertension (2000) 1.35
Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol (2001) 1.35
Performance of screening tests for child physical abuse in accident and emergency departments. Health Technol Assess (2008) 1.34
Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats. Diabetologia (2007) 1.31
Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia. Am J Trop Med Hyg (1992) 1.29
Recombinant Plasmodium falciparum glutamate rich protein; purification and use in enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1991) 1.28
Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (2001) 1.26
Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun (1999) 1.26
Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia (1997) 1.24
Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect (2004) 1.20
Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis. Am J Physiol Renal Physiol (2004) 1.20
Performance of European laboratories testing serum samples for Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (1996) 1.20
Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization. Exp Clin Immunogenet (1985) 1.16
Visual and somatosensory evoked cortical potentials in multiple sclerosis. J Neurol Neurosurg Psychiatry (1979) 1.16
Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int (1997) 1.16
Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Health Technol Assess (2007) 1.15
Baby Check and the Avon infant mortality study. Arch Dis Child (1991) 1.15
Risk factors for recent toxoplasma infection in pregnant women in Naples. Epidemiol Infect (1996) 1.14
Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products. J Clin Invest (1997) 1.12
Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. BJOG (2005) 1.11
Mother-to-child transmission of HIV-1 and infant feeding practice. AIDS (2001) 1.10
Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study. AIDS (1996) 1.10
Detection of Toxoplasma gondii DNA by polymerase chain reaction in cerebrospinal fluid from AIDS patients with cerebral toxoplasmosis. J Infect Dis (1992) 1.10
Reliability of expert interpretation of retinal photographs for the diagnosis of toxoplasma retinochoroiditis. Br J Ophthalmol (2002) 1.10
Neonatal screening for congenital toxoplasmosis in the Poznań region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J (2000) 1.09
Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol (1999) 1.09
Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UK. HIV Med (2008) 1.09
Multicenter evaluation of a fluorometric enzyme immunocapture assay to detect toxoplasma-specific immunoglobulin M in dried blood filter paper specimens from newborns. J Clin Microbiol (1996) 1.07
Chronic Ureaplasma urealyticum amnionitis associated with abruptio placentae. Obstet Gynecol (1986) 1.07
Studies on the effect of distamycin A on the DNA dependent RNA polymerase system. Biochem Biophys Res Commun (1971) 1.07
Congenital toxoplasmosis: a prospective survey in Brussels. Br J Obstet Gynaecol (1984) 1.07
The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients. Clin Exp Immunol (1994) 1.06
Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy. Intern Med J (2005) 1.06
Interlaboratory comparison of polymerase chain reaction for the detection of Toxoplasma gondii DNA added to samples of amniotic fluid. Eur J Clin Microbiol Infect Dis (1996) 1.06
The prevention of anaemia in pregnancy in primigravidae in the guinea savanna of Nigeria. Ann Trop Med Parasitol (1986) 1.05
A controlled trial of lambda-cyhalothrin-impregnated bed nets and/or dapsone/pyrimethamine for malaria control in Sierra Leone. Am J Trop Med Hyg (1998) 1.05
Identification of a human immunodominant B-cell epitope within the GRA1 antigen of Toxoplasma gondii by phage display of cDNA libraries. Int J Parasitol (2001) 1.04
Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey. Br J Ophthalmol (2006) 1.04
Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney Int (2000) 1.03
Infant feeding and risk of mother-to-child transmission of HIV-1 in São Paulo State, Brazil. São Paulo Collaborative Study for Vertical Transmission of HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.03
T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine. Proc Natl Acad Sci U S A (1988) 1.03
Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznań region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies. J Clin Microbiol (2001) 1.02
Gall stones in Jamaican children with homozygous sickle cell disease. Arch Dis Child (1989) 1.02
What do we know about risk factors for infection in humans with Toxoplasma gondii and how can we prevent infections? Zoonoses Public Health (2009) 1.01
Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat. Cardiovasc Res (2007) 1.01